About Inventys
Inventys is a company based in Mumbai (India) founded in 2005 by Deepak B Birewar. It operates as a Managed Services and Direct-to-Consumer (D2C). Inventys has raised $64.34 million across 4 funding rounds from investors including Multi Organics, Plutus Wealth and India Inflection Opportunity Fund. The company has 218 employees as of October 13, 2025. Inventys offers products and services including Exclusive Manufacturing, CDMO Services, and Specialty Chemicals. Inventys operates in a competitive market with competitors including Viyash, Blue Jet Healthcare, Shogun Organics, Aparna Pharmaceuticals and Ami organics, among others.
- Headquarter Mumbai, India
- Employees 218 as on 13 Oct, 2025
- Founders Deepak B Birewar
- Stage Minicorn
-
Sectors
Chemicals & MaterialsHealthcare Industrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inventys Research Company
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$6.96 M (USD)-53.61as on Mar 31, 2023
-
Net Profit
-$1.38 M (USD)-184.77as on Mar 31, 2023
-
EBITDA
$279.77 K (USD)-93.13as on Mar 31, 2023
-
Total Equity Funding
$64.34 M (USD)
in 4 rounds
-
Latest Funding Round
$29.49 M (USD), Series B
Apr 20, 2022
-
Investors
Multi Organics
& 9 more
-
Employee Count
218
as on Oct 13, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inventys
Inventys offers a comprehensive portfolio of products and services, including Exclusive Manufacturing, CDMO Services, and Specialty Chemicals.
Exclusive chemical manufacturing is provided for unique customer needs.
CDMO services are offered for life sciences molecule advancement.
Specialty chemicals are produced for pharma and electronics industries.
People of Inventys
Unlock access to complete
Unlock access to complete
Funding Insights of Inventys
Inventys has successfully raised a total of $64.34M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $29.49 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Inventys
Inventys has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Multi Organics, Plutus Wealth and India Inflection Opportunity Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Investment services are provided to emerging pre-IPO enterprises.
|
Locked | Locked | Locked | |
|
Leading manufacturer of speciality chemicals and advanced intermediates with global reach.
|
Locked | Locked | Locked |
Investor details for Inventys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inventys
Investment portfolio details for Inventys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inventys
Detailed financials for Inventys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inventys Comparisons
Peer comparison for Inventys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inventys
Inventys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Blue Jet Healthcare, Shogun Organics, Aparna Pharmaceuticals and Ami organics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and intermediates are manufactured by Viyash as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
|
|
| Locked | Locked | Locked |
Contract manufacturer of chemicals used in household insecticide products
|
|
| Locked | Locked | Locked |
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
|
|
| Locked | Locked | Locked |
Advanced API intermediates are manufactured for pharmaceutical use.
|
Detailed competitors of Inventys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inventys
Complete news archive for Inventys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inventys
Inventys was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Inventys is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Inventys is a funded company, having raised a total of $64.34M across 4 funding rounds to date.
As of Oct 13, 2025, the latest employee count at Inventys is 218.
Annual revenue of Inventys is $6.96M as on Mar 31, 2023.
Inventys Research Company is engaged in providing exclusive manufacturing and CDMO services to innovators in life sciences, focusing on crop protection, pharmaceuticals, and specialty chemicals. Operations are supported by expertise in flow chemistry, green chemistry, and deep backward integration. Services are extended across sectors like healthcare and electronics with a commitment to sustainability and innovation. Manufacturing capacities are being expanded to position Inventys among Indias top specialty chemical producers.
Inventys's top competitors include Viyash, Shogun Organics and Blue Jet Healthcare.
Inventys offers Exclusive Manufacturing, CDMO Services, and Specialty Chemicals.
Inventys has 10 investors. Key investors include Multi Organics, Plutus Wealth, India Inflection Opportunity Fund, Arpit Khandelwal, and Arpit Khandelwal.
The valuation of Inventys is $249.61M as of Apr 2022.